Biolinq

San Diego, CA · Founded 2012 · Privately Held (backing)

Developer of a biomonitoring health platform designed to improve metabolic health. Biolinq is based in San Diego, CA and was founded in 2012. It was valued at $407 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $313 million across 8 recorded rounds; the latest was a $90 million later-stage round in Mar 2025.

PMV mark · valuation
$407.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$312.8M
Last round
Later Stage VC
Mar 2025

Who backs Biolinq?

36 investors
InvestorType
MedTech InnovatorOther
National Institutes of HealthOther
CONNECT(San Diego)Other
Pegasus Tech VenturesVenture capital
Mark CubanHigh net worth
Alpha Wave GlobalGrowth equity
M VenturesVenture capital
Able PartnersVenture capital
G9 Ventures—
Standish Spring Investments—
+ 26 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biolinq investors

36 investors are on record for Biolinq, including MedTech Innovator, National Institutes of Health, CONNECT(San Diego) and Pegasus Tech Ventures. The later-stage round in Mar 2025 drew 45 investors.

Free account
More of Biolinq with a free account
  • ·The complete investor list: 36 names
  • ·Watch Biolinq: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 36 firms already write checks for companies like Biolinq. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View